Replimune Group, Inc.
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against canc…
Biotechnology
US, Woburn [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
Replimune Group, Inc. has no acquisition track records yet.
M&A Deals · History
Replimune Group, Inc. has no acquisition track records yet.